Earnings
OXFD
21.99
+0.05%
0.01
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2019-12-31
73.71M
73.71M
19.29M
54.42M
50.74M
8.70M
--
--
--
79.83M
--
-6.12M
2.30M
--
68.00K
2.30M
-3.76M
-2.42M
-1.34M
--
-1.34M
-1.34M
-469.00K
--
-0.05
FY 2018-12-31
59.75M
59.75M
16.83M
42.93M
52.45M
8.12M
--
--
0.00
82.58M
--
-22.82M
-1.69M
--
-271.00K
-1.69M
-24.78M
-37.29M
12.51M
--
12.51M
12.51M
108.27M
--
0.47
FY 2017-12-31
54.73M
54.73M
18.47M
36.26M
54.50M
10.84M
--
--
-3.48M
81.16M
--
-26.43M
-4.96M
--
-209.00K
-4.96M
-31.59M
-19.77M
-11.83M
--
-11.83M
-11.83M
-21.06M
--
-0.50
FY 2016-12-31
46.99M
46.99M
16.49M
30.50M
45.78M
9.37M
--
--
-1.21M
72.19M
--
-25.21M
500.00K
--
-646.00K
500.00K
-25.35M
-3.77M
-21.58M
--
-21.58M
-21.58M
-771.00K
--
-0.97
FY 2015-12-31
62.78M
62.78M
29.54M
33.24M
46.41M
11.00M
--
--
--
86.96M
--
-24.18M
-210.00K
--
54.00K
-210.00K
-24.33M
146.00K
-24.48M
--
-24.48M
-24.48M
--
--
-1.12

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out OXFD latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Oxford Immunotec recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.